THE COST-EFFECTIVENESS OF THE LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM (LNG-IUS, MIRENA®) FOR THE TREATMENT OF HEAVY MENSTRUAL BLEEDING IN THE UNITED STATES

被引：0
|
作者：
Ganz, M. [1 ]
Shah, D. [1 ]
Gidwani, R. [1 ]
Filonenko, A. [2 ]
Su, W. [3 ]
Pocoski, J. [4 ]
Law, A. [4 ]
机构：
[1] United BioSource Corp, Lexington, MA USA
[2] Bayer Schering Pharma AG, Berlin, Germany
[3] United BioSource Corp, Bethesda, MD USA
[4] Bayer HealthCare Pharmaceut Inc, Wayne, NJ USA
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.598
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A107 / A107
页数：1
相关论文
共 50 条
  • [1] The Cost-Effectiveness of the Levonorgestrel-Releasing Intrauterine System for the Treatment of Idiopathic Heavy Menstrual Bleeding in the United States
    Ganz, Michael L.
    Shah, Dhvani
    Gidwani, Risha
    Filonenko, Anna
    Su, Wenqing
    Pocoski, Jennifer
    Law, Amy
    VALUE IN HEALTH, 2013, 16 (02) : 325 - 333
  • [2] COST-EFFECTIVENESS OF LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM (LNG-IUS) FOR THE TREATMENT OF DYSFUNCTIONAL UTERINE BLEEDING (DUB) IN SPAIN
    Lete, I
    Cristobal, I
    Febrer, L.
    Crespo, C.
    Hernandez, F. J.
    Arbat, A.
    Serrano, D.
    Brosa, M.
    VALUE IN HEALTH, 2008, 11 (06) : A423 - A423
  • [3] Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil
    Valeria Bahamondes, M.
    de Lima, Yuri
    Teich, Vanessa
    Bahamondes, Luis
    Monteiro, Ilza
    CONTRACEPTION, 2012, 86 (03) : 244 - 250
  • [4] Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception
    Trussell, James
    Hassan, Fareen
    Henry, Nathaniel
    Pocoski, Jennifer
    Law, Amy
    Filonenko, Anna
    CONTRACEPTION, 2014, 89 (05) : 451 - 459
  • [5] The Effectiveness of Levonorgestrel-Releasing Intrauterine System in the Treatment of Heavy Menstrual Bleeding
    Eralil G.J.
    The Journal of Obstetrics and Gynecology of India, 2016, 66 (Suppl 1) : 505 - 512
  • [6] Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS)
    Heikinheimo, Oskari
    Gemzell-Danielsson, Kristina
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2012, 91 (01) : 3 - 9
  • [7] Cost-effectiveness of a strategy starting with the levonorgestrel intrauterine system (LNG-IUS) versus a strategy starting with endometrial ablation in the treatment of heavy menstrual bleeding
    van den Brink, M. J.
    Beelen, P.
    Herman, M. C.
    Geomini, P. M.
    Dekker, J. H.
    Vermeulen, K.
    Bongers, M. Y.
    Berger, M. Y.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 105 - 106
  • [8] BLEEDING PATTERN AND SATISFACTION IN CONSECUTIVE LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM (LNG-IUS) USERS
    Heikinheimo, O.
    Gemzell-Danielsson, K.
    Schmelter, T.
    Inki, P.
    FERTILITY AND STERILITY, 2013, 100 (03) : S56 - S56
  • [9] Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma
    Giannopoulos, T
    Butler-Manuel, S
    Tailor, A
    GYNECOLOGIC ONCOLOGY, 2004, 95 (03) : 762 - 764
  • [10] Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding
    Hurskainen, R
    Paavonen, J
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2004, 16 (06) : 487 - 490
12345